Trump Is Being Sued For Rescheduling Marijuana By Doctors And A Pharmaceutical Company Who Are ‘Aggrieved’ By The Move
A coalition of doctors, substance misuse professionals, and a cannabis-focused biopharmaceutical company has filed a lawsuit against President Trump and administration officials challenging the federal rescheduling of marijuana. The plaintiffs claim the rescheduling action violated administrative procedures by lacking prior notice-and-comment requirements.
Filed under Court Ruling in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Marijuana Opponents Attack Government Analysis Behind Rescheduling Recommendation On Second Day Of DEA Hearing
Marijuana Moment Asks DEA Judge To Allow Livestreaming Of Rescheduling Hearing For Transparent Public Access
Marijuana Rescheduling Appeal Process ‘Remains Pending’ Despite Trump’s Executive Order, DEA Says In New Filing
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
DEA Defends Stance That Synthetic Cannabis Compound HHC Is Federally Banned In Response To Industry Lawsuits
Hemp Companies Sue DEA, Challenging Agency’s Claim That Synthetic Cannabis Compound HHC Is Federally Banned
Stay current on Minnesota cannabis
Browse more court ruling updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.